000 01431 a2200385 4500
005 20250513224854.0
264 0 _c20010118
008 200101s 0 0 eng d
022 _a0165-5728
024 7 _a10.1016/s0165-5728(00)00414-8
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aDelgado, M
245 0 0 _aVIP and PACAP inhibit Fas ligand-mediated bystander lysis by CD4(+) T cells.
_h[electronic resource]
260 _bJournal of neuroimmunology
_cJan 2001
300 _a78-88 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
650 0 4 _aAnimals
650 0 4 _aCD4-Positive T-Lymphocytes
_xdrug effects
650 0 4 _aCell Line
650 0 4 _aCytotoxicity, Immunologic
_xdrug effects
650 0 4 _aFas Ligand Protein
650 0 4 _aFemale
650 0 4 _aMembrane Glycoproteins
_xphysiology
650 0 4 _aMice
650 0 4 _aMice, Inbred BALB C
650 0 4 _aMice, Inbred C57BL
650 0 4 _aMice, Inbred DBA
650 0 4 _aNeuropeptides
_xpharmacology
650 0 4 _aPituitary Adenylate Cyclase-Activating Polypeptide
650 0 4 _aVasoactive Intestinal Peptide
_xpharmacology
650 0 4 _afas Receptor
_xphysiology
700 1 _aGanea, D
773 0 _tJournal of neuroimmunology
_gvol. 112
_gno. 1-2
_gp. 78-88
856 4 0 _uhttps://doi.org/10.1016/s0165-5728(00)00414-8
_zAvailable from publisher's website
999 _c11050226
_d11050226